We are live on ! Find out more
DERM

Dermira, Inc.
DERM

Delisted

DERM was delisted on the 19th of February, 2020.

119 hedge funds and large institutions have $317M invested in Dermira, Inc. in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 38 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $292M → $317M (+$25.1M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 38

4% less call options, than puts

Call options by funds: $4.73M | Put options by funds: $4.94M

5.02% less ownership

Funds ownership: 87.33%82.3% (-5%)

7% less funds holding

Funds holding: 128119 (-9)

27% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 26

Holders
119
Holders Change
-9
Holders Change %
-7.03%
% of All Funds
2.71%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
37
Reduced
38
Closed
26
Calls
$4.73M
Puts
$4.94M
Net Calls
-$205K
Net Calls Change
-$921K

DERM Hedge Fund Activity: Q2 2018 in Review

119 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Dermira, Inc. (DERM) for Q2 2018, worth a combined $317M — up 8.6% from $292M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of DERM and 19 opened new positions — a net loss of 7 holders — while 38 trimmed existing stakes and 37 added.

The largest buyer was OrbiMed, opening a new position worth an estimated $9.62M. The largest seller was Avoro Capital Advisors, cutting an estimated $14.8M.

  • 119 institutional investors held Dermira, Inc. (DERM) as of Q2 2018, down from 128 in Q1 2018.
  • Funds reported $317M of Dermira, Inc. stock for Q2 2018, up 8.6% quarter-over-quarter.
  • 19 funds opened new Dermira, Inc. positions in Q2 2018 and 26 closed out, a net change of -7 holders.
  • The largest Dermira, Inc. buyer in Q2 2018 was OrbiMed, an estimated $9.62M added.
  • The largest Dermira, Inc. seller in Q2 2018 was Avoro Capital Advisors, an estimated $14.8M sold.

Based on aggregated 13F filings for Q2 2018.